200,000+ products from a single source!

sales@angenechem.com

Home > Quinoline > 67339-62-2

67339-62-2

67339-62-2 | 2-[2-(4-(2-METHOXYPHENYL)PIPERAZIN-1-YL)ETHYL]-4,4-DIMETHYL-1,3-(2H,4H)-ISOQUINOLINDIONE DIHYDROCHLORIDE

CAS No: 67339-62-2 Catalog No: AG0062N0 MDL No:

Product Description

Catalog Number:
AG0062N0
Chemical Name:
2-[2-(4-(2-METHOXYPHENYL)PIPERAZIN-1-YL)ETHYL]-4,4-DIMETHYL-1,3-(2H,4H)-ISOQUINOLINDIONE DIHYDROCHLORIDE
CAS Number:
67339-62-2
Molecular Formula:
C24H31Cl2N3O3
Molecular Weight:
480.4272
IUPAC Name:
2-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-4,4-dimethylisoquinoline-1,3-dione
InChI:
InChI=1S/C24H29N3O3/c1-24(2)19-9-5-4-8-18(19)22(28)27(23(24)29)17-14-25-12-15-26(16-13-25)20-10-6-7-11-21(20)30-3/h4-11H,12-17H2,1-3H3
InChI Key:
JFNKXGOEOQCXDM-UHFFFAOYSA-N
SMILES:
COc1ccccc1N1CCN(CC1)CCN1C(=O)c2ccccc2C(C1=O)(C)C.Cl.Cl
UNII:
M7H349ZZ5T

Properties

Complexity:
629  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
407.221g/mol
Formal Charge:
0
Heavy Atom Count:
30  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
407.514g/mol
Monoisotopic Mass:
407.221g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
53.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.4  

Literature

Title Journal
Rapid turnover of glycogen in memory formation. Neurochemical research 20121101
Dexmedetomidine induces both relaxations and contractions, via different {alpha}2-adrenoceptor subtypes, in the isolated mesenteric artery and aorta of the rat. The Journal of pharmacology and experimental therapeutics 20101201
Postjunctional α2C-adrenoceptors mediate vasoconstriction in rat tail artery: influence of precontraction and temperature on vasoreactivity. Naunyn-Schmiedeberg's archives of pharmacology 20101201
The roles of alpha2-adrenoceptor subtypes in the control of cervical resistance in the late-pregnant rat. European journal of pharmacology 20090801
[The effect of the ARC 239 on the myometrial and cervical action in the rat, in vitro]. Acta pharmaceutica Hungarica 20090101
Different roles of alpha2-adrenoceptor subtypes in non-pregnant and late-pregnant uterine contractility in vitro in the rat. Neurochemistry international 20071001
Multiplexing G protein-coupled receptors in microarrays: a radioligand-binding assay. Analytical biochemistry 20070615
Characterization of the postjunctional alpha 2C-adrenoceptor mediating vasoconstriction to UK14304 in porcine pulmonary veins. British journal of pharmacology 20070501
The presence of beta2-adrenoceptors sensitizes alpha2A-adrenoceptors to desensitization after chronic epinephrine treatment. BMC pharmacology 20070101
Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action. Journal of medicinal chemistry 20061228
Pharmacological characterization and autoradiographic distribution of alpha2-adrenoceptor antagonist [3H]RX 821002 binding sites in the chicken brain. Neuroscience 20060811
Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. European journal of pharmacology 20041011
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. Behavioural brain research 20040831
Noradrenergic modulation of serotonin release in rat dorsal and median raphé nuclei via alpha(1) and alpha(2A) adrenoceptors. Neuropharmacology 20010901
Effect of dexmedetomidine on the release of [3H]-noradrenaline from rat kidney cortex slices: characterization of alpha2-adrenoceptor. Neurochemistry international 20010401
Postjunctional alpha(2C)-adrenoceptor contractility in human saphenous vein. European journal of pharmacology 20010216
[Interactions between alpha 1, alpha 2 and beta receptors in the blood pressure effects of adrenaline and noradrenaline in the dog]. Journal de pharmacologie 19830101

Related Products

© 2019 Angene International Limited. All rights Reserved.